Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: Potential alternative as drug delivery system prior to cataract surgery

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 6, 2006, Pages 547-554

  Mouly, Stéphane ^a   Mahé, Isabelle ^a   Haouchine, Belkacem ^a   Sanson Le Pors, Marie José ^a   Blain, Patrick ^a   Tillet, Yves ^b   Dewailly, Jean ^c   Mongold, Jean Jacques ^d   Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b WHITE TILLET Consultants ^*  (France)

^c BLUESTAT   (France)

^d Ioltech   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; MYDRIASERT; MYDRIATIC AGENT; PHENYLEPHRINE; TROPICAMIDE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CONTAMINATION; BLOOD PRESSURE; BURNING SENSATION; CARDIOVASCULAR DISEASE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TOLERANCE; EYE DISCOMFORT; EYE PAIN; EYE PHOTOGRAPHY; FEMALE; FOREIGN BODY; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INTRAOCULAR HYPERTENSION; KERATITIS; MALE; MYDRIASIS; NORMAL HUMAN; OPHTHALMIC INSERT; PARALYTIC ILEUS; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PUPIL; RANDOMIZED CONTROLLED TRIAL; REFRACTOMETER; STANDARD; STROKE; TACHYCARDIA; VERTIGO; VOLUNTEER;

ADOLESCENT; ADULT; BLOOD PRESSURE; CATARACT EXTRACTION; CONJUNCTIVA; DEMOGRAPHY; DIASTOLE; DRUG DELIVERY SYSTEMS; DRUG TOLERANCE; ENDPOINT DETERMINATION; FEMALE; HEALTH; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYDRIATICS; PHENYLEPHRINE; PUPIL; SYSTOLE; TROPICAMIDE;

BACTERIA (MICROORGANISMS);

EID: 33646733671     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_362.x     Document Type: Article

References (28)

1. Brown M. M. G. C. Brown G. L. Spaeth : Lack of side effects from topically administered 10% phenylephrine eyedrops. Arch. Ophtalmol. 1980, 98, 487 489.
2. Chieng D. S. R. Schoenwald : Fluorometric determination of phenylephrine hydrochloride by liquid chromatography in human plasma. J. Pharm. Sci. 1985, 74, 562 564.
3. Chin K. W. N. M. Law M. K. Chin : Phenylephrine eye drops in ophthalmic surgery. A clinical study on cardiovascular effects. Med. J. Malaysia 1994, 49, 158 163.
4. Congdon N. G. D. S. Friedman T. Lictman : Important causes of visual impairment in the world today. J. Amer. Med. Assoc. 2003, 290, 2057 2060.
5. Cordonnier M. A. Pereleux A. Herode A. Zanen : Le traitement de l'oeil sec par le lacrisert. Bull. Soc. Belge. Ophtal. 1985, 212, 65 69.
6. Craig E. W. P. G. Griffiths : Effect on mydriasis of modifying the volume of phenylephrine drops. Brit. J. Ophthalmol. 1991, 75, 222 223.
7. Fraunfelder F. T. A. F. Scafidi : Possible adverse effects from topical ocular 10% phenylephrine. Amer. J. Ophtalmol. 1978, 85, 447 453.
8. Fraunfelder F. T. S. M. Meyer : Systemic reactions to ophthalmic drug preparations. Med. Toxicol. 1987, 2, 287 293.
9. Hakim O. J. R. B. Orton W. Cadera : Topical 2.5% and 5% phenylephrine: comparison of effects on heart rate and blood pressure. Can. J. Ophtalmol. 1990, 25, 336 339.
10. Hammond C. J. H. Snieder T. D. Spector O. E. Gilbert : Factors affecting pupil size after dilatation: The twin eye study. Brit. J. Ophtalmol. 2000, 84, 1173 1176.
11. Hoffman B. B. R. J. Lefkowitz : Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In : The pharmacological basis of therapeutics, 9th ed.. Eds.: J. G. Hardman L. E. Limbird P. B. Molinoff R. W. Ruddon A. Goodman. Gilman, McGraw-Hill, 1992, Section II, pp. 199 248.
12. Korobelnik J. F. C. Tavera M. B. Renaud-Rougier S. El Meski J. Colin : L'insert ophtalmique Mydriasert®, une alternative aux collyres pour la mydriase pré-angiographique. J. Fr. Ophtalmol. 2004, 27, 897 902.
13. Lai Y. K. : Adverse effect of intraoperative phenylephrine 10%: Case report. Brit. J. Ophtalmol. 1989, 73, 468 469.
14. Lee Y. C. J. Millard G. J. Negvesky S. I. Butrus S. H. Yalkowsky : Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. Int. J. Pharm. 1999, 182, 121 126.
15. Levet L. O. Touzeau S. Scheer V. Borderie L. Laroche : Etude de la dilatation pupillaire par l'insert ophthalmique Mydriasert®. J. Fr. Ophthalmol. 2004, 27, 1099 1108.
16. Lim D. L. M. Batilando V. S. Rajadurai : Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity. J. Paediatr. Child. Health. 2003, 39, 318 320.
17. Mydriasert® : Investigator Brochure. IOLTECH® Laboratoires, La Rochelle, France, August 2001.
18. Nagataki S. S. Mishima : Pharmacokinetics of instilled drugs in the human eye. Int. Ophtalmol. Clin. 1980, 20, 33 48.
19. Pascoe P. J. J. E. Ilkiw J. Stiles E. M. Smith : Arterial hypertension associated with topical ocular use of phenylephrine in dogs. J. Amer. Vet. Med. Assoc. 1994, 205, 1562 1564.
20. Patel C. K. T. A. Bui G. Gregariou S. Pereira A. Chopdar B. K. McLeod : A pre-operative mydriatic regimen using a single application of tropicamide novel ophthalmic delivery system and guttae phenylephrine 10%. Eye 1995, 9, 337 340.
21. Prause J. U. : Treatment of keratoconjunctivitis sicca with lacrisert. Scand. J. Rheumatol. 1986, 61, 261 263.
22. Reichl S. J. Bednarz C. C. Müller-Goymann : Human corneal equivalent as cell culture model for in vitro drug permeation studies. Brit. J. Ophthalmol. 2004, 88, 560 565.
23. Rengstorff R. H. C. B. Doughty : Mydriatic and cycloplegic drugs. A review of ocular and systemic complications. Amer. J. Optiom. Physiol. Optics. 1982, 59, 162 177.
24. Saettone M. F. L. Salminen : Ocular inserts for topical delivery. Adv. Drug. Deliv. Rev. 1995, 16, 95 106.
25. Salminen L. A. Urtti H. Kujari M. Juslin : Prolonged pulse entry of pilocarpine with a soluble drug insert. Graefes Arch. Clin. Exp. Ophthalmol. 1983, 221, 96 99.
26. Scat Y. C. Chaumeil L. Battelier : Prélèvements endo-oculaires et endophtalmies: étude des germes isolés au Centre Hospitalier Neuro-ophtalmologique des Quinze-Vingts. Med. Mal. Inf. 1996, 26, 1159 1163.
27. Thylefors B. A. D. Negrel R. Pararajasegaram K. Y. Ddadzie : Global data on blindness. Bull. World Health. Organ. 1995, 73, 115 121.
28. Zimmerman T. J. T. M. Wheeler : Miotics: Side effects and ways to avoid them. Ophthalmology 1982, 89, 76 80.